loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 1ede7e9a A835 4d1d A4fe A2014a3fe1ed Applno 202611 Form Tablet Extended Release Oral Dosage 25mg - Drug Product Composition: Myrbetriq

    Menu

    Myrbetriq

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,234Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202611 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 25MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MIRABEGRON(UNII: MVR3JL3B2V)
    (MIRABEGRON - UNII:MVR3JL3B2V)     		MIRABEGRON25mg